JP2018514592A5 - - Google Patents

Download PDF

Info

Publication number
JP2018514592A5
JP2018514592A5 JP2018508628A JP2018508628A JP2018514592A5 JP 2018514592 A5 JP2018514592 A5 JP 2018514592A5 JP 2018508628 A JP2018508628 A JP 2018508628A JP 2018508628 A JP2018508628 A JP 2018508628A JP 2018514592 A5 JP2018514592 A5 JP 2018514592A5
Authority
JP
Japan
Prior art keywords
dry eye
composition
subject
pharmaceutically acceptable
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018508628A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018514592A (ja
JP7245649B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/030142 external-priority patent/WO2016179007A1/en
Publication of JP2018514592A publication Critical patent/JP2018514592A/ja
Publication of JP2018514592A5 publication Critical patent/JP2018514592A5/ja
Application granted granted Critical
Publication of JP7245649B2 publication Critical patent/JP7245649B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018508628A 2015-05-01 2016-04-29 眼疾患を治療するためのアディポネクチンペプチド模倣薬（関連出願の相互参照） Active JP7245649B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562156127P 2015-05-01 2015-05-01
US62/156,127 2015-05-01
PCT/US2016/030142 WO2016179007A1 (en) 2015-05-01 2016-04-29 Adiponectin peptidomimetics for treating ocular disorders

Publications (3)

Publication Number Publication Date
JP2018514592A JP2018514592A (ja) 2018-06-07
JP2018514592A5 true JP2018514592A5 (https=) 2022-10-27
JP7245649B2 JP7245649B2 (ja) 2023-03-24

Family

ID=57218292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018508628A Active JP7245649B2 (ja) 2015-05-01 2016-04-29 眼疾患を治療するためのアディポネクチンペプチド模倣薬（関連出願の相互参照）

Country Status (12)

Country Link
US (6) US10987401B2 (https=)
EP (3) EP4014985A1 (https=)
JP (1) JP7245649B2 (https=)
KR (2) KR20170141692A (https=)
CN (3) CN115919996A (https=)
AU (3) AU2016257724B2 (https=)
CA (3) CA3191203A1 (https=)
DK (1) DK3288577T3 (https=)
ES (1) ES2903448T3 (https=)
IL (1) IL272449A (https=)
SG (1) SG11202001140UA (https=)
WO (2) WO2016179007A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919996A (zh) 2015-05-01 2023-04-07 雅利斯塔制药公司 用于治疗眼科疾病的脂联素拟肽
WO2018165218A1 (en) * 2017-03-09 2018-09-13 Allysta Pharmaceuticals, Inc Peptides for dry eye disease
CN107149676A (zh) * 2017-05-05 2017-09-12 杨硕 脂联素和脂联素/胰岛素混合液在改善及治疗眼表角膜上皮及神经损伤中的应用
WO2019061491A1 (en) * 2017-09-30 2019-04-04 Pro Sunfun Biotech Research And Development Co., Ltd. PEPTIDE FOR OCULAR CARE, COMPOSITION AND METHOD OF USE THEREOF
CN109912685B (zh) * 2017-12-13 2022-05-06 三凡生技研发股份有限公司 眼睛保护胜肽及其组合物及使用该胜肽的用途
CN112165954A (zh) * 2018-03-23 2021-01-01 阿奇生物外科有限公司 用于治疗眼病的sap和拟肽
JP7688471B2 (ja) * 2018-10-24 2025-06-04 アリスタ ファーマスーティカルス インク． アディポネクチンペプチド模倣組成物
JP7699426B2 (ja) * 2018-11-30 2025-06-27 ロート製薬株式会社 光線による障害からの細胞保護用眼科組成物
US11229549B2 (en) * 2019-09-18 2022-01-25 Vance M. Thompson Tear transplantation and multi-part contact lens with absorbent portion
JP7419499B2 (ja) 2019-09-18 2024-01-22 アルコン インク． 湿式充填のソフトヒドロゲル眼用インサート
US11213551B1 (en) 2021-04-05 2022-01-04 Korb Research, Llc. Ocular treatment compositions and methods of use thereof
WO2023069549A1 (en) * 2021-10-20 2023-04-27 Stealth Biotherapeutics Inc. Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions
WO2023069255A1 (en) * 2021-10-20 2023-04-27 Stealth Biotherapeutics Inc. Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions
WO2023107796A1 (en) * 2021-12-11 2023-06-15 The Regents Of The University Of California Ophthalmic formulations for macular degeneration
WO2024180472A1 (en) 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts
KR102609115B1 (ko) * 2023-06-08 2023-12-05 주식회사 엔큐라젠 펩타이드를 포함하는 안구 질환의 치료용 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
DE4437604A1 (de) 1994-10-21 1996-04-25 Basf Ag Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
EE05214B1 (et) 1998-04-28 2009-10-15 Applied Research Systems ARS Holding N.V. Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
GB9814527D0 (en) 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
CA2473781A1 (en) * 2002-01-18 2003-07-31 Protemix Corporation Limited Glycoisoforms of adiponectin and uses thereof
MX2007013430A (es) * 2005-04-29 2008-03-19 Univ California Peptidos y peptidos mimeticos para tratar patologias caracterizadas por una respuesta inflamatoria.
WO2012142142A2 (en) * 2011-04-12 2012-10-18 Temple University - Of The Commonwealth System Higher Education Adiponectin receptor agonists and methods of use
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
RU2652063C2 (ru) * 2012-10-26 2018-04-24 Форсайт Вижн5, Инк. Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
CN115919996A (zh) * 2015-05-01 2023-04-07 雅利斯塔制药公司 用于治疗眼科疾病的脂联素拟肽

Similar Documents

Publication Publication Date Title
JP2018514592A5 (https=)
JP5583310B2 (ja) 眼球の症状の予防及び治療のための眼科用製剤
CA2806942C (en) Compounds for the treatment/prevention of ocular inflammatory diseases
US20070265353A1 (en) Eye Drops for the Treatment of Dry Eye
KR20120104980A (ko) 각막 및 결막의 병변을 치료하기 위한 프로스타글란딘 ｆ2알파 및 유사체의 용도
EP3768296B1 (en) Sap and peptidomimetics for treatment of eye disease
CA2909806C (en) Oral pharmaceutical composition for preventing or treating dry eye syndrome comprising rebamipide or a prodrug thereof
JP6267003B2 (ja) ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤
JP2024079810A (ja) キレート剤、浸透促進剤およびヒドロキシエチルセルロースを含む眼科疾患治療用製剤
CN116367829A (zh) 用于干眼的预防剂、改善剂和治疗剂
AU2006260184B2 (en) Prophylactic or therapeutic agent for corneal/conjunctival disease
AU2011282679A1 (en) Preservative free bimatoprost solutions
JP5605072B2 (ja) 角結膜疾患の予防又は治療剤
JP4249185B2 (ja) 涙液異常の治療のための眼科用組成物
RU2679319C1 (ru) Гелеобразная искусственная слеза с антисептическим и репаративным действием
JP2022505832A (ja) アディポネクチンペプチド模倣組成物
RU2847424C1 (ru) Контактная линза для доставки лекарственного средства
JP4778515B2 (ja) 角膜疾患治療剤
JP2002205944A (ja) ファルネシル酢酸を有効成分とする角結膜疾患治療剤
WO2002038149A1 (en) Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient
WO2023160499A1 (zh) 一种肽、含有所述肽的眼用药物组合物及其用途
US20210052582A1 (en) Methods of use and pharmaceutical compositions of a selective syk inhibitor
JP2007063218A (ja) 角膜疾患治療剤
WO2005058932A1 (ja) 涙液層安定化剤